Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trifiletti

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Minerva Medica|April 24, 2001
Correlation between family history of hypertension and haemostatic disordersA Trifiletti, R Scamardi, M Cincotta, et al.
Panminerva Medica|May 7, 1999
Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive diseaseA Trifiletti, R Scamardi, M A Pizzoleo, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 15, 1980
[Platelet aggregation in normal and hypertensive subjects during cold pressor test]A Saitta, A Trifiletti, C Mangano, et al.
Panminerva Medica|November 14, 1997
Haemostatic effects of iloprost in patients with lower limb ischemiaA Trifiletti, R Scamardi, M A Pizzoleo, et al.
Minerva Cardioangiologica|September 10, 1999
Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenonS Bartolone, A Trifiletti, G De Nuzzo, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 15, 1980
[Hypertriglyceridemia, IRI and platelet aggregation]C Mangano, A Trifiletti, A Saitta, et al.
Panminerva Medica|June 1, 1997
Haemostatic parameters in patients with primitive venous hypertensionA Trifiletti, R Scamardi, M A Pizzoleo, et al.
Thrombosis Research|April 16, 2008
Haemostatic effects of phytoestrogen genistein in postmenopausal womenA Trifiletti, A Gaudio, A Lasco, et al.
Journal of Endocrinological Investigation|November 10, 2005
Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?A Gaudio, A Lasco, N Morabito, et al.
Journal of Endocrinological Investigation|March 26, 2008
Bisphosphonates in the treatment of thalassemia-associated osteoporosisA Gaudio, N Morabito, A Xourafa, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Minerva Medica|April 24, 2001
Correlation between family history of hypertension and haemostatic disordersA Trifiletti, R Scamardi, M Cincotta, et al.
Panminerva Medica|May 7, 1999
Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive diseaseA Trifiletti, R Scamardi, M A Pizzoleo, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 15, 1980
[Platelet aggregation in normal and hypertensive subjects during cold pressor test]A Saitta, A Trifiletti, C Mangano, et al.
Panminerva Medica|November 14, 1997
Haemostatic effects of iloprost in patients with lower limb ischemiaA Trifiletti, R Scamardi, M A Pizzoleo, et al.
Minerva Cardioangiologica|September 10, 1999
Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenonS Bartolone, A Trifiletti, G De Nuzzo, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 15, 1980
[Hypertriglyceridemia, IRI and platelet aggregation]C Mangano, A Trifiletti, A Saitta, et al.
Panminerva Medica|June 1, 1997
Haemostatic parameters in patients with primitive venous hypertensionA Trifiletti, R Scamardi, M A Pizzoleo, et al.
Thrombosis Research|April 16, 2008
Haemostatic effects of phytoestrogen genistein in postmenopausal womenA Trifiletti, A Gaudio, A Lasco, et al.
Journal of Endocrinological Investigation|November 10, 2005
Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?A Gaudio, A Lasco, N Morabito, et al.
Journal of Endocrinological Investigation|March 26, 2008
Bisphosphonates in the treatment of thalassemia-associated osteoporosisA Gaudio, N Morabito, A Xourafa, et al.
Pageof 3